
Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Methylamine (40% w/w in H2O)
CAS:Controlled ProductFormula:CH5NColor and Shape:Colourless LiquidMolecular weight:31.06Bosentan-d4
CAS:Controlled Product<p>Applications Labelled Bosentan (B675900). A mixed endothelin receptor antagonist. Used as a vasodilator. Antihypertensive.<br>References Clozel, M., et al.: J. Pharmacol. Exp. Ther., 270, 228 (1994), Gutsch, G., et al.: Cardiovasc. Drugs Ther., 10, 717 (1996), Weber, C., et al.: Clin Pharmacol. Ther., 60, 124 (1996), Krum, H., et al.: N. Engl. J. Med., 338, 784 (1998)<br></p>Formula:C27H25D4N5O6SColor and Shape:NeatMolecular weight:555.64Mivacurium Chloride (mixture of isomers)
CAS:Controlled ProductFormula:C58H80N2O14·2ClColor and Shape:NeatMolecular weight:1100.17Apixaban
CAS:<p>Applications A potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation.<br>References Luettgen, J. M., et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T., et al.: J. Thromb. Thrombol., 31, 310 (2011); Barrett, Y. C., et al.: Thromb. Haemos., 105, 181 (2011);<br></p>Formula:C25H25N5O4Color and Shape:White To Off-WhiteMolecular weight:459.505-Desisobutyl,5-(2-Methyl-prop-1-en-1-yl) Butalbital
CAS:Controlled Product<p>Applications 5-(2-Methyl-1-propen-1-yl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione is a potential impurity of Butalbital (B690100), a controlled substance (depressant). Sedative, hypnotic.<br>References Inaba, T., et al.: Clin. Pharmacol. Ther., 18, 558 (1975), Fritch, D., et al.: J. Anal. Toxicol., 33, 569 (2009), Wille, S., et al.: Ther. Drug Monit., 31, 511 (2009),<br></p>Formula:C11H14N2O3Color and Shape:NeatMolecular weight:222.24Ivermectin
CAS:Controlled Product<p>Applications Semi-synthetic derivative of Abamectin; consists of a mixture of not less than 80% component B1a and not more than 20% component B1b. Anthelmintic (Onchocerca).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Chabala, J.C., et al.: J. Med. Chem., 23, 1134 (1980); Campbell, W.C., et al.: Science, 221, 823 (1983); Bennett, J.L., et al.: Parasitol. Today, 4, 226 (1988); Plaisier, A.P., et al.: J. Infect. Dis., 172, 204 (1995);<br></p>Formula:C48H74O14·C47H72O14Color and Shape:White To Off-WhiteMolecular weight:1736.16Brinzolamide
CAS:Controlled Product<p>Applications Carbonic anhydrase inhibitor. Antiglaucoma agent.<br>References Silver, L.H., et al.: Am. J. Ophthalmol., 126, 400 (1998), Davies, N., et al.: Clin. Exp. Pharmacol. Physiol., 27, 558 (2000), Stave, J., et al.: Ophthalmologe, 99, 276 (2002),<br></p>Formula:C12H21N3O5S3Color and Shape:NeatMolecular weight:383.51(2S,3aR,7aS)-Octahydroindole-2-carboxylic Acid (~90%, contains cis)
CAS:Controlled ProductFormula:C9H15NO2Color and Shape:NeatMolecular weight:169.22Dihexyl Aminoquat Impurity of Colesevelam
CAS:Formula:C18H43N3HBrBrMolecular weight:301.6 : 80.9 : 2(79.9)N-Carbamoyl Oxcarbazepine
Controlled Product<p>Applications N-Carbamoyl Oxcarbazepine is an impurity of Oxcarbazepine (O869250), a metabolite of Eslicarbazepine acetate, (BIA 2-093), a novel central nervous system drug. A keto derivative of Carbamazepine. Used as an anticonvulsant.<br>References Dam., M., et al.: Epilepsy Res., 3, 70 (1989), Beydoun, A., et al.: Expert Opin. Pharmacother., 3, 59 (2001),<br></p>Formula:C16H13N3O3Color and Shape:NeatMolecular weight:295.295-Desmethyl-3-methyl Leflunomide
CAS:Controlled Product<p>Impurity Leflunomide EP Impurity E<br>Applications 5-Desmethyl-3-methyl Leflunomide (Leflunomide EP Impurity E) is the 3-methyl-isomer of Leflunomide (L322750), as a poisonous impurity.<br></p>Formula:C12H9F3N2O2Color and Shape:NeatMolecular weight:270.211-Chloroethyl Cyclohexyl Carbonate
CAS:<p>Applications 1-Chloroethyl Cyclohexyl Carbonate is a genotoxic impurity used in the synthesis of Candesartan Cilexetil. an angiotensin II receptor antagonist.<br>References Kakasaheb, N. et al.: Int. J. Pharm. Sci., 6, 370 (2014); Mao, Y. et al.: Heterocycles, 81, 1503 (2010);<br></p>Formula:C9H15ClO3Color and Shape:NeatMolecular weight:206.673’-Amino-2’-Hydroxy-[1,1’]biphenyl-3-carboxylic Acid
CAS:Controlled Product<p>Applications 3’-Amino-2’-Hydroxy-[1,1’]Biphenyl-3-carboxylic Acid is used in the synthesis of monoethanolamine salts. A hydrazine cleavage product from Eltrombopag (E508000), an agonist of the Thrombopoietin (Tpo) receptor, used as treatment for thrombocytopenia<br>References Bussel, J., et al.: New Eng. J. Med., 357, 2237 (2007), Marsilje, T., et al.: Bioorg. Med. Chem. Lett., 18, 5259 (2008), Alper, P., et al.: Bioorg. Med. Chem. Lett., 18, 5255 (2008),<br></p>Formula:C13H11NO3Color and Shape:NeatMolecular weight:229.2314’-Hydroxy Diclofenac-D4
CAS:Controlled ProductFormula:C142H4H7Cl2NO3Color and Shape:NeatMolecular weight:316.17

